Science Explorer Interactive view Map
Company · Saarbrücken · Germany

URSAPHARM (Germany)

ursapharm.de/en/homeROR OpenAlex
Research works
16
▲ 47% vs 2013–17
Citations
211
13.0 per fractional work
Top-10% rate
6.7%
record average 16.5%
Open access
60%
world 28%

Not ranked overall: URSAPHARM (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.75× its world share, 0 worksBiochemistry, Geneti…Neuroscience: 1.38× its world share, 0 worksNeuroscienceComputer Science: 0.36× its world share, 0 worksComputer ScienceEngineering: 0.50× its world share, 0 worksEngineeringMaterials Science: 1.07× its world share, 0 worksMaterials ScienceMedicine: 3.87× its world share, 2 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.

Which research topics does URSAPHARM (Germany) publish most on?

By volume in 2022–2025: COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, SARS-CoV-2 detection and testing and Allergic Rhinitis and Sensitization.

COVID-19 Clinical Resear…0COVID-19 Clinical Research Studies: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksSARS-CoV-2 detection and testing: 0 fractional worksAllergic Rhinitis and Sensitization: 0 fractional worksDermatology and Skin Diseases: 0 fractional worksPeriodontal Regeneration and Treatments: 0 fractional worksAsthma and respiratory diseases: 0 fractional worksAdditive Manufacturing and 3D Printing Technologies: 0 fractional works3D Printing in Biomedical Research: 0 fractional worksExtracellular vesicles in disease: 0 fractional works
Infectious DiseasesImmunology and AllergyDermatologyUrology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  4. 4 Allergic Rhinitis and Sensitization Immunology and Allergy 0 works
  5. 5 Dermatology and Skin Diseases Dermatology 0 works
  6. 6 Periodontal Regeneration and Treatments Urology 0 works
  7. 7 Asthma and respiratory diseases Physiology 0 works
  8. 8 Additive Manufacturing and 3D Printing Technologies Automotive Engineering 0 works
  9. 9 3D Printing in Biomedical Research Biomedical Engineering 0 works
  10. 10 Extracellular vesicles in disease Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available60.3%not open39.7%

World: 28% of research is openly available.

with international co-authors25.1%domestic only74.9%

World: 19% is written across borders.

How has URSAPHARM (Germany)'s research output changed?

Output in 2018–2022 was 47% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Saarbrücken

All research institutions in Saarbrücken

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.